3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Withdrawn
1
Unknown
1
Recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Fatigue
1
Breast Neoplasms
1
Interventions
Specimen Handling
5
Surveys and Questionnaires
4
Observation
4
Blood Specimen Collection
4
Drug Therapy
3
Chemoradiotherapy
3
Surgical Procedures, Operative
2
Electrocardiography
2
Echocardiography
2
Capecitabine
2
Biopsy
2
trifluridine tipiracil drug combination
1
tegafur-gimeracil-oteracil
1
somapacitan
1
olverembatinib
1
lorlatinib
1
lenvatinib
1
gallium 68 PSMA-11
1
brexucabtagene autoleucel
1
axicabtagene ciloleucel
1
Zoledronic Acid
1
Tumor Burden
1
Telemedicine
1
Tegafur
1
Stents
1
Spermine Synthase
1
S 1 (combination)
1
Robotic Surgical Procedures
1
Rituximab
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Observational
×
Zoledronic Acid
×
Clear all
NCT04488614
2020-07-30
PBCB
Helse Stavanger HF
Enrolling by invitation
1,200 enrolled